Zepp Health (NYSE:ZEPP) Hits New 52-Week High - Here's What Happened

Key Points

• Zepp Health's stock reached a new 52-week high of $40.24 during mid-day trading, significantly up from a previous close of $33.86.
• Analysts have set varied price targets, with Fundamental Research assigning a $13.87 price objective and a "buy" rating, while Wall Street Zen upgraded the stock to a "hold" rating.
• In its latest quarter, Zepp Health reported a loss of ($1.13) EPS with a revenue of $38.54 million and a negative return on equity of 24.19%.

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report) shares reached a new 52-week high during trading on Monday . The stock traded as high as $38.88 and last traded at $40.24, with a volume of 196002 shares trading hands. The stock had previously closed at $33.86.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded Zepp Health to a "hold" rating in a report on Saturday, August 16th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, the company has an average rating of "Buy" and a consensus target price of $13.87.

Zepp Health Stock Performance

The stock has a market cap of $572.86 million, a PE ratio of -8.18 and a beta of 1.11. The stock has a fifty day simple moving average of $14.82 and a two-hundred day simple moving average of $6.91. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.78 and a current ratio of 1.10.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.